March 22 (Reuters) - Cardiome Pharma Corp COM.TO :
* HEALTH CANADA ACCEPTS CARDIOME'S XYDALBA NEW DRUG SUBMISSION AND GRANTS PRIORITY REVIEW
* CARDIOME PHARMA CORP - EXPECTS TO RECEIVE AN APPROVAL DECISION FOR XYDALBA DURING Q3 OF 2018
March 22 (Reuters) - Cardiome Pharma Corp COM.TO :
* HEALTH CANADA ACCEPTS CARDIOME'S XYDALBA NEW DRUG SUBMISSION AND GRANTS PRIORITY REVIEW
* CARDIOME PHARMA CORP - EXPECTS TO RECEIVE AN APPROVAL DECISION FOR XYDALBA DURING Q3 OF 2018